A contemporary disease model of AD, which converged the amyloid and tau theories, suggested that the deposition of Aβ peptide is an upstream event that is associated with downstream synaptic dysfunction, tau deposition, neurodegeneration, and eventual cognitive decline [6]. The gene discussed is MAPT; the disease is Alzheimer disease.